About: CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Latest price: $0.00 (+32.14%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
CEROW NASDAQ CERo Therapeutics Holdings Inc
CERo Therapeutics Holdings Inc share price
CEROW price activity
Last Price
$0.000
Change (24hr)
0.00 USD (32.14%)
Volume
4
Volume (4w avg)
-
Open
$0.00
Day Range
$0.00 - $0.00
Previous Close
$0.00
Last Trade
15 Sep, 4:16 pm GMT+0
Delayed
15 Sep, 4:16 pm GMT+0
CEROW price performance
Delayed
15 Sep, 4:16 pm GMT+0
CEROW Market Signals